Literature DB >> 29327370

Role of immune system in tumor progression and carcinogenesis.

Shishir Upadhyay1, Nidhi Sharma1, Kunj Bihari Gupta2, Monisha Dhiman2.   

Abstract

Tumor micro-environment has potential to customize the behavior of the immune cell according to their need. In immune-eliminating phase, immune cells eliminate transformed cells but after tumor establishment innate and adaptive immune cells synergistically provide shelter as well as fulfill their requirement that helps in progression. In between eliminating and establishment phase, equilibrium and escaping phase regulate the immune cells response. During immune-escaping, (1) the antigenic response generated is either inadequate, or focused entirely on tolerance, and (2) immune response generated is specific and effective, but the tumor skips immune recognition. In this review, we are discussing the critical role of immune cells and their cytokines before and after the establishment of tumor which might play a critical role during immunotherapy.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  adoptive T cell transfer; chemokines; cytokines; immune surveillance; micro-environment

Mesh:

Substances:

Year:  2018        PMID: 29327370     DOI: 10.1002/jcb.26663

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

Review 1.  Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration.

Authors:  Kirsten Lee Fetah; Benjamin J DiPardo; Eve-Mary Kongadzem; James S Tomlinson; Adam Elzagheid; Mohammed Elmusrati; Ali Khademhosseini; Nureddin Ashammakhi
Journal:  Small       Date:  2019-11-13       Impact factor: 13.281

Review 2.  Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.

Authors:  Aswathy R Devan; Bhagyalakshmi Nair; Ayana R Kumar; Balachandran S Vinod; Lekshmi R Nath
Journal:  Mol Biol Rep       Date:  2021-10-20       Impact factor: 2.316

Review 3.  The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

Authors:  Daniela Bruni; Helen K Angell; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2020-08-04       Impact factor: 60.716

Review 4.  Breast cancer models: Engineering the tumor microenvironment.

Authors:  Gokhan Bahcecioglu; Gozde Basara; Bradley W Ellis; Xiang Ren; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2020-02-09       Impact factor: 8.947

5.  Hydrogen peroxide-induced oxidative stress and its impact on innate immune responses in lung carcinoma A549 cells.

Authors:  Shishir Upadhyay; Saurabh Vaish; Monisha Dhiman
Journal:  Mol Cell Biochem       Date:  2018-06-25       Impact factor: 3.396

6.  Unsupervised Hierarchical Clustering Identifies Immune Gene Subtypes in Gastric Cancer.

Authors:  Jing Cao; Jiao Gong; Xinhua Li; Zhaoxia Hu; Yingjun Xu; Hong Shi; Danyang Li; Guangjian Liu; Yusheng Jie; Bo Hu; Yutian Chong
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

Review 7.  The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia.

Authors:  Vanessa D'Antongiovanni; Matteo Fornai; Carolina Pellegrini; Laura Benvenuti; Corrado Blandizzi; Luca Antonioli
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

8.  Alternative splicing of helicase-like transcription factor (Hltf): Intron retention-dependent activation of immune tolerance at the feto-maternal interface.

Authors:  Gurvinder Kaur; Rebecca A Helmer; Lisa A Smith; Raul Martinez-Zaguilan; Jannette M Dufour; Beverly S Chilton
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

9.  Higher Levels of Pre-operative Peripheral Lymphocyte Count Is a Favorable Prognostic Factor for Patients With Stage I and II Rectal Cancer.

Authors:  Ying-Ying Zhang; Wan-Qing Li; Zhen-Fa Li; Xiao-Hua Guo; Shen-Kang Zhou; Aifen Lin; Wei-Hua Yan
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

10.  Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma.

Authors:  Heike Loeser; Max Kraemer; Florian Gebauer; Christiane Bruns; Wolfgang Schröder; Thomas Zander; Hakan Alakus; Arnulf Hoelscher; Reinhard Buettner; Philipp Lohneis; Alexander Quaas
Journal:  J Immunol Res       Date:  2020-09-22       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.